S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|GSK and Genmab announce top-line results from a Phase III study of ofatumumab versus physicians' choice for bulky fludarabine-refractory CLL|
|GSK and Genmab Receive EU Authorization for Arzerra(tm) (ofatumumab) as First-Line Treatment for Chronic Lymphocytic Leukemia (CLL) in Combination with Chlorambucil or Bendamustine for Patients Ineligible for Fludarabine-based Therapy|
|Glaxo investigating possible bribes in UAE: report|
|Five Prime: Glaxo Exercises Option for Rights to Muscle-Disease Products|
|GlaxoSmithKline Names RBS's Philip Hampton as Chairman (2014/9/25)|
|UPDATE: Glaxo slides in London after earnings warning|
|UPDATE: Glaxo shares fall in London after earnings warning|
|GSK to Name Philip Hampton as Next Chairman -Sky News (2014/9/24)|
|GSK Names RBS's Philip Hampton as Chairman (2014/9/25)|
|Codexis Announces Technology Collaboration and License Agreement With GSK|
Click above to view more mutual fund data and stats for gsk - GlaxoSmithKline PLC.